• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Brown, Zoda promoted at INC Research

Brown, Zoda promoted at INC Research

August 27, 2015
CenterWatch Staff

Raleigh, N.C.-based INC Research, a global phase I to IV CRO, has announced the promotions of Bekki Brown to executive vice president, clinical development and general medicine, and Tom Zoda, Ph.D., to executive vice president, clinical development, central nervous system (CNS).

Brown and Zoda are responsible for providing executive leadership for two of the company’s therapeutic business units. The appointments reinforce INC's continued focus on providing customers with therapeutically specialized project teams to maximize efficiency and collaboration through proven expertise and strong business acumen. 

Michael Gibertini, Ph.D., the company's president of clinical development, said, “INC is focused on providing specialized teams and experts in particular disciplines that fully understand each therapy area and how to best address customers’ needs. By structuring teams in this way, we are able to deliver unique insights that provide a clear advantage in accelerating new therapies to market for the benefit of patients in need.”

Brown, who has been with INC since 2001, provides global leadership for the company’s General Medicine business unit, which specializes in conducting clinical trials in areas ranging from infectious disease, respiratory disease, immunology and inflammation, gastrointestinal diseases, urology and women’s health. Since joining the business unit in 2010, she has led operations and guided the group to its highest-ever level of performance. During her tenure at INC, she has made material contributions to the architecture of the company’s Trusted Process project management methodology. Brown began her career at INC  in project management, overseeing CNS studies, and has held other positions including leadership roles in operations management and global training.

Zoda, who has worked in the pharmaceutical and CRO industry for more than 20 years, has extensive experience designing, managing and overseeing clinical trials for the development of CNS therapeutics. He takes over the CNS unit from Gibertini, who now focuses on driving innovation and leveraging efficiencies across all of INC’s therapeutic business units for the benefit of customers. Since joining INC in 2009, Zoda has directed and overseen large multi-center global trials focused on psychiatric and neurological indications in areas such as schizophrenia, Alzheimer's disease, depression, anxiety, multiple sclerosis and epilepsy. He has been instrumental in helping the company grow its CNS team to more than 900 professionals and in strengthening its position in the marketplace as an industry leader in CNS clinical trials.

 

Upcoming Events

  • 17May

    Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing